BIORELIANCE CORPORATION

Bioreliance Corporation specializes in advanced microbiological and biopharmaceutical testing services, with deep expertise in endotoxin detection, sterility assurance, and cell line storage and characterization. The company delivers critical quality control and safety validation for biologics, vaccines, and therapeutic products, employing validated assays such as LAL (Limulus Amebocyte Lysate) and membrane filtration techniques to meet USP, EP, and FDA regulatory standards. Their work in tumorigenicity and oncologenicity follow-up testing demonstrates specialized capability in assessing biological safety of cell substrates and biologics, supporting the development of complex biotechnological products. Bioreliance’s technical proficiency spans cell banking, viral clearance validation, and aseptic processing support, positioning them as a trusted partner in the end-to-end biopharmaceutical lifecycle. The company maintains a consistent, long-standing relationship with the Department of Health and Human Services, providing essential laboratory services across its agencies, including CDC and FDA-related programs. Their work supports public health initiatives involving vaccine safety, biologics licensing, and infectious disease research, often involving sensitive cell lines such as Vero and MDCK. This sustained engagement reflects a proven ability to meet stringent regulatory timelines and compliance requirements in mission-critical environments. Bioreliance operates primarily within the testing laboratories and medical laboratories sectors, with a clear focus on biotechnology development and analytical services for life sciences. Their niche lies in supporting GMP-compliant manufacturing environments where product purity and biological safety are non-negotiable. They serve as a specialized provider for pharmaceutical and biotech firms navigating regulatory pathways, particularly in the absence of in-house testing infrastructure. Bioreliance Corporation is a small business entity based in Rockville, Maryland, with no federal certifications on record. Their geographic positioning in the National Capital Region places them at the heart of federal biomedical research and regulatory activity, enabling close collaboration with federal agencies and industry partners in the biopharma ecosystem.